Unknown

Dataset Information

0

HucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury.


ABSTRACT: Exosomes are small biological membrane vesicles secreted by various cells, including mesenchymal stem cells (MSCs). We previously reported that MSC-derived exosomes (MSC-Ex) can elicit hepatoprotective effects against toxicant-induced injury. However, the success of MSC-Ex-based therapy for treatment of liver diseases and the underlying mechanisms have not been well characterized. We used human umbilical cord MSC-derived exosome (hucMSC-Ex) administrated by tail vein or oral gavage at different doses and, in engrafted liver mouse models, noted antioxidant and anti-apoptotic effects and rescue from liver failure. A single systemic administration of hucMSC-Ex (16 mg/kg) effectively rescued the recipient mice from carbon tetrachloride (CCl4)-induced liver failure. Moreover, hucMSC-Ex-derived glutathione peroxidase1 (GPX1), which detoxifies CCl4 and H2O2, reduced oxidative stress and apoptosis. Knockdown of GPX1 in hucMSCs abrogated antioxidant and anti-apoptotic abilities of hucMSC-Ex and diminished the hepatoprotective effects of hucMSC-Ex in vitro and in vivo. Thus, hucMSC-Ex promote the recovery of hepatic oxidant injury through the delivery of GPX1.

SUBMITTER: Yan Y 

PROVIDER: S-EPMC5368592 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury.

Yan Yongmin Y   Jiang Wenqian W   Tan Youwen Y   Zou Shengqiang S   Zhang Hongguang H   Mao Fei F   Gong Aihua A   Qian Hui H   Xu Wenrong W  

Molecular therapy : the journal of the American Society of Gene Therapy 20170106 2


Exosomes are small biological membrane vesicles secreted by various cells, including mesenchymal stem cells (MSCs). We previously reported that MSC-derived exosomes (MSC-Ex) can elicit hepatoprotective effects against toxicant-induced injury. However, the success of MSC-Ex-based therapy for treatment of liver diseases and the underlying mechanisms have not been well characterized. We used human umbilical cord MSC-derived exosome (hucMSC-Ex) administrated by tail vein or oral gavage at different  ...[more]

Similar Datasets

| S-EPMC8109102 | biostudies-literature
| S-EPMC10150843 | biostudies-literature
| S-EPMC9344707 | biostudies-literature
| S-EPMC7132622 | biostudies-literature
| S-EPMC5871719 | biostudies-literature
| S-EPMC2886705 | biostudies-literature
| S-EPMC7484346 | biostudies-literature
| S-EPMC5801895 | biostudies-literature
| S-EPMC7205986 | biostudies-literature
| S-EPMC4976377 | biostudies-literature